Mission and vision
Commercially viable biobased and biodegradable plastic!
BluCon Biotech GmbH was founded in June 2017 and has its research laboratories and offices at the BioCampus, Cologne. The company continues to develop a unique technology by which L-lactic acid can be produced at lowest possible production costs so that the bioplastic poly lactic acid (PLA) will become commercially competitive to fossil fuel based plastics.
Such technology development has been initiated and carried out by Direvo Industrial Biotech GmbH in Cologne. Patents and know how have been acquired from Direvo by Zheijiang Youcheng group, Hangzhou, China. Chinese startup company, Dehong Biotech Ltd. has been entrusted to drive the commercialization of BluCon technology. Dehong in turn has entrusted BluCon Biotech GmbH to carry out strain and process development towards commercial process. BluCon Biotech GmbH is also partnering with Dehong, Hangzhou, to build and operate a biotechnology laboratory in Hangzhou and implement BluCon technology there.
BluCon Biotech GmbH collaborates with Shanghai Tong Jie Liang Biomaterials Ltd. (TJL) for the production of PLA and thus is very well integrated downstream. TJL is also building a research and development laboratory in Hangzhou, Zheijiang, China.
Besides developing BluCon technology to commercial stage, BluCon Biotech GmbH serves as a platform to acquire further technologies in the field of applied biotechnology. With its core team, the company shows outstanding expertise in microbiology of extremophilic bacteria, in strain and process development and in project management. It is very well connected both in Germany and internationally.
This is us
Dr. Albrecht Läufer
Dr. Andreas Lischka
Head of Finance & Administration
Dr. Vitaly Svetlichny
Head of Research
Dr. Marco Krämer
Head of Laboratory
Get in touch
BluCon Biotech GmbH
50829 Cologne, Germany